Claudio Zamagni
AuthID: R-00G-N0M
1
TITLE: Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
AUTHORS: Ignace Vergote; Giovanni Scambia; David M O'Malley; Ben Van Calster; Sang Yoon Park; Josep M del Campo; Werner Meier; Aristotelis Bamias; Nicoletta Colombo; Robert M Wenham; Al Covens; Christian Marth; Mansoor Raza Mirza; Judith R Kroep; Haijun Ma; Cheryl A Pickett; Bradley J Monk; Sang Yoon Park; Yong Sang Song; Yulia Makarova; ...More
PUBLISHED: 2019, SOURCE: The Lancet Oncology, VOLUME: 20, ISSUE: 6
AUTHORS: Ignace Vergote; Giovanni Scambia; David M O'Malley; Ben Van Calster; Sang Yoon Park; Josep M del Campo; Werner Meier; Aristotelis Bamias; Nicoletta Colombo; Robert M Wenham; Al Covens; Christian Marth; Mansoor Raza Mirza; Judith R Kroep; Haijun Ma; Cheryl A Pickett; Bradley J Monk; Sang Yoon Park; Yong Sang Song; Yulia Makarova; ...More
PUBLISHED: 2019, SOURCE: The Lancet Oncology, VOLUME: 20, ISSUE: 6
2
TITLE: Phase II multicenter, uncontrolled trial of sorafenib in patients with metastatic breast cancer
AUTHORS: Giulia Bianchi; Sibylle Loibl; Claudio Zamagni; Stefania Salvagni; Guenter Raab; Salvatore Siena; Nicole Laferriere; Carol Peña; Chetan Lathia; Loredana Bergamini; Luca Gianni;
PUBLISHED: 2009, SOURCE: Anti-Cancer Drugs, VOLUME: 20, ISSUE: 7
AUTHORS: Giulia Bianchi; Sibylle Loibl; Claudio Zamagni; Stefania Salvagni; Guenter Raab; Salvatore Siena; Nicole Laferriere; Carol Peña; Chetan Lathia; Loredana Bergamini; Luca Gianni;
PUBLISHED: 2009, SOURCE: Anti-Cancer Drugs, VOLUME: 20, ISSUE: 7
INDEXED IN: 
CrossRef
CrossRef